Pavel Kosina - Infectious Diseases

Author Information

Pavel Kosina is affiliated with the Department of Infectious Diseases at University Hospital, Charles University in Prague, located in Hradec Kralove, Czech Republic. His work primarily focuses on infectious diseases, with specific research interests spanning vaccine immunogenicity, pharmacokinetics, and biotransformation processes.

Research Contributions

Pavel Kosina has made significant contributions to the field of infectious diseases through his extensive research on vaccines and their long-term efficacy. His studies have explored various facets of immunization, including the persistence of antibody titers, the impact of maternal vaccination on infant immune responses, and the safety and immunogenicity of vaccinations in immunocompromised populations such as HIV-1 infected persons. Additionally, his research extends to the metabolism of compounds like silymarin flavonolignans, providing valuable insights into drug metabolism and the interaction of herbal extracts with human metabolic enzymes.

Aliases

Pavel Kosina is also known in academic circles by the names P Kosina and P. Kosina, which may appear in various publications and citations.

Publication and Citation Metrics

Metric	Value
Total Papers	81
Citation Count	1670
h-index	24

Publications:

Stability and ultraviolet A photostability of silymarin polyphenols and its consequences for practical use in dermatology

DOI: 10.1016/j.jphotochem.2022.113897

Year: 2022

Persistence of hSBA titers elicited by the meningococcal serogroup B vaccine menB-FHbp for up to 4 years after a 2- or 3-dose primary series and immunogenicity, safety, and tolerability of a booster dose through 26 months.

DOI: 10.1016/j.vaccine.2021.06.005

Year: 2021

Impact of maternal diphtheria-tetanus-acellular pertussis vaccination on pertussis booster immune responses in toddlers: Follow-up of a randomized trial.

DOI: 10.1016/j.vaccine.2021.02.001

Year: 2021

The Adjuvanted Recombinant Zoster Vaccine Confers Long-term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase III Clinical Trials (ZOE-50 and ZOE-70).

DOI: 10.1093/cid/ciab629

Year: 2021

Metabolism of 2,3-Dehydrosilybin A and 2,3-Dehydrosilybin B: A Study with Human Hepatocytes and Recombinant UDP-Glucuronosyltransferases and Sulfotransferases

DOI: 10.3390/antiox10060954

Year: 2021

Immunogenicity and safety of rapid scheme vaccination against tick-borne encephalitis in HIV-1 infected persons

DOI: 10.1017/S0950268821000194

Year: 2021

Identification of Human Sulfotransferases Active towards Silymarin Flavonolignans and Taxifolin

DOI: 10.3390/metabo10080329

Year: 2020

Tdap maternal immunization and infant follow-up trials: Immunogenicity, transplacental transfer of pertussis antibodies, safety following pertussis immunization during pregnancy and its impact on infant pertussis immune response

DOI: 10.17632/RY6M6ZJ35W.1

Year: 2020

Biotransformation of Silymarin Flavonolignans by Human Fecal Microbiota

DOI: 10.3390/metabo10010029

Year: 2020

Effect of bilberry extract (Vaccinium myrtillus L.) on drug-metabolizing enzymes in rats.

DOI: 10.1016/j.fct.2019.04.051

Year: 2019

How Does Genomics Aid in Identifying Pathogens?

What is Lyme Disease?

How is Bovine Tuberculosis Transmitted?

What is the World Health Organization (WHO)?

How Effective Are Insecticides?

Which Infections Are Most Affected?

What Are the Common Types of Infectious Diseases?

How Do Pathogens Evade the Immune System?

What are the global statistics?

What is the Global Impact of Malaria?

Partnered Content Networks

Relevant Topics